40th Pharmacovigilance UK & EU 2026
40th Pharmacovigilance UK & EU 2026
11 & 12 March 2026
Sheraton Skyline, Heathrow, London, UK
5 Reasons to attend the event

Knowledge
Gain insights from experts, researchers, and professionals to stay updated on the latest pharma advancements.

An Agenda Made For You
High quality content that addresses your biggest challenges and uncovering hidden opportunities.

Cutting-Edge Insights
Discover the latest trends, innovations, and breakthroughs shaping the future of the pharmaceutical industry.

Networking
Connect with peers, industry leaders, and collaborators to exchange ideas and explore new opportunities.

Practical Takeaways
Walk away with actionable strategies, real-world case studies, and learn best practices to implement in your work.

Knowledge
Gain insights from experts, researchers, and professionals on the latest pharma advancements.

An Agenda Made For You
High quality content that addresses your biggest challenges and uncovering hidden opportunities.

Cutting-Edge Insights
Explore the latest trends, innovations, and breakthroughs driving the future of the pharmaceutical industry.

Networking
Connect with peers, industry leaders, and collaborators to exchange ideas and explore new opportunities.

Practical Takeaways
Walk away with practical strategies, case studies, and proven best practices to apply in real-time.
Key Focus Areas

Event Speakers
Download Brochure
Event Schedule
Meet to learn and network with your conference colleagues.
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:30 – Chairperson opening remarks
Speaker

PAV RISHIRAJ
Director, Head of Pharmacovigilance
Ipsen
09:40 – Beyond compliance: How we can do more for patients in PV
BEYOND COMPLIANCE
Patient voices in PV are still underutilized. We can move beyond compliance and do our best to make safety truly patient-centered.
This presentation will cover the current state, why it matters to include patient voices and how we can do more and move from “checking the box” to doing our best for patients.
Speaker

BEGUM BENLI PEKER
Head of Patient Safety EU Hub
Bristol-Myers Squibb
10:20 – Safety monitoring in clinical studies
SAFETY
- Proactive monitoring
- Timely detection and management of safety issues
- Interaction & communication with stakeholders.
Speaker

RUDI SCHEERLINCK
Safety Strategy Lead – Oncology
Healthcare Business of Merck
10:50 – Morning Coffee/Tea & Networking
11:20 – Keynote Panel Discussion: Pharmacovigilance: Innovations, Challenges & Global Best Practices - Best practices & the way forward
LATEST UPDATES & HOT TOPICS
Moderator

RUDI SCHEERLINCK
Safety Strategy Lead – Oncology
Healthcare Business of Merck
Panellists

REMCO M. DIAB
Sr. Dir. Lead Global Safety Officer Immunology & Inflammation
Sanofi

VALENTINA MANCINI
Senior Director Pharmacovigilance, QPPV
Shionogi Europe

LEONARDO PEREIRA
Clinical Safety Director
Roche

SUMIT MUNJAL
Global Head of Medical Safety
Otsuka Pharmaceuticals

SIMON ASHWORTH
Head of Pharmacovigilance & Medical Safety
MENARINI Group
12:20 – Solution Provider Presentation
For sponsorship opportunities please contact info.uk@virtueinsight.com
12:50 – Networking luncheon
13:50 – Panel Discussion – Patient-Centric PV: Elevating Drug Safety through Engagement. Making drug safety monitoring more proactive, data-driven, and human-centered
PATIENT CENTRIC PV
Moderator

YVONNE NANCIU
Country Head Pharmacovigilance Deputy EU QPPV
Bayer
Panellists

ABIDALI FAZAL
Safety Science Director
Roche

AZZA ELGHARABLY
Associate Director, Patient Safety Scientist
AstraZeneca

RISHI CHOPRA
Head of International PV & Global PV Operations | Dep. UK
QPPV
CSL Behring

MICHAEL VON FORSTNER
Chief Scientific Officer
MedGenie

CINTHYA GALICIA QUINTANAR
Senior Manager, Country Safety Lead
Pfizer

SANJEEV SRIVASTAV
Signal Management Lead
BioNTech
14:50 – Medical Device Vigilance: Important Considerations to Comply With the EU MDR
MEDICAL DEVICES
- Medical Device Vigilance vs Pharmacovigilance
- Causality Assessment
- Clinical Reporting & Postmarketing Reporting Requirements
- Reporting Formats
Speaker

MARTINA GOMES
Head, Reg Affairs – CH, South Asia
Bayer
15:10 – Afternoon Tea/Coffee
15:40 – Future of pharmacovigilance - Making medicines safe in an increasingly complex world
MARKET TRENDS & WAY AHEAD
- Pharmacovigilance: What comes next for the industry?
- Transforming the science at the heart of pharmacovigilance
- Building trust and openness with technology
- Automating to innovate
- Does the shift towards emerging markets pose a risk to drug safety and biased data reports?
Speaker

SHREYA DESHPANDE
Global Development Quality Manager
Novartis
16:10 - Panel Discussion – The Evolving Era of PV Outsourcing: Recent Developments, Innovations and Best Practices
OUTSOURCING
Moderator

PAV RISHIRAJ
Director, Head of Pharmacovigilance
Ipsen
Panellists

GYORGY ZORENYI
Senior Medical Director, Medical Safety
Jazz Pharma

LEONA HOUGHTON
Vice President, Global Safety (Ex-US)
Mundipharma

ZINA SADEQ
Director, Regional PV & Alliance Management, UK QPPV
Amicus Therapeutics

PHILLIP EICHORN
Global Head of Drug Safety
Amryt Pharma
17:00 - Chairperson’s closing remarks and end of conference
17:10 – 18:10 - Networking Drinks Session
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:20 – Welcome address and Opening Remarks
09:30 – Keynote Address – Strategy for global PV system inspection readiness
INSPECTION READINESS
- Who needs to be ready
- Factors for consideration when supporting global inspections
- Common areas of non-compliance
- Management of responses
Speaker

RAJ K BHOGAL
Sr. Director, R&D Business Strategy & Operations
Jazz Pharmaceuticals (UK)
10:10 – Keynote Panel Discussion: Pharmacovigilance for Tomorrow: Navigating Challenges and Uncovering Opportunities
CHALLENGES & OPPORTUNITIES
- Tackle data overload and integration barriers in effective PV implementation.
- Examine the gaps between pre-marketing potential and post-marketing reality.
- Question if accelerated drug approvals compromise patient safety.
- Explore complexities in adopting AI and automation within PV systems.
- Discuss challenges in global literature monitoring for drug safety.
- Identify misconceptions, misuse, and underrecognized factors in ADR causation.
Moderator

VIPIN SETHI
VP International Business, Head Global PV Function
Cadila
Panellists

RISHI JAIN
Country Medical Head
Novartis

INDU NAMBIAR
Pharmacovigilance Lead & Country Safety Head
Sanofi

SAKSHI SHRIVASTAVA DESAI
Director, LMS regional Lead APAC
Johnson & Johnson

KRUNAL DALAL
Head Medical Affairs
GSK

GIRISH SANE
GM & Head Pharmacovigilance
Bristol Laboratories

CHAITANYA KULKARNI
GM Pharmacovigilance
Marksans Pharma
11:00 – Morning Coffee/Tea & Discussion
11:30 – Panel Discussion: Patient-Centric Pharmacovigilance: Amplifying the Patient Voice in Drug Safety
PATIENT SAFETY
- Address unconscious bias in pharmacovigilance and explore mitigation strategies.
- Trace the shift from reactive to proactive patient safety models.
- Examine the role of patient input in signal detection and ADR prevention.
- Highlight the importance of protecting vulnerable patient groups.
- Discuss challenges in patient engagement, including tech access and language barriers.
- Emphasize the value of patient-reported outcomes in improving safety reporting and empowerment.
- Explore how public awareness enhances pharmacovigilance systems and data quality.
Moderator

VISHWAS SOVANI
Founder Director
Pharmawisdom
Panellists

VAIBHAV SALVI
Director & Head – Clinical Study Unit, India & South East Asia
Sanofi

SOURABH FULMALI
Global Medical Director – Respiratory
GSK

RENUKA NEOGI
Head & Deputy GM – Global Clinical Quality Management
Sun Pharma

JAMAL BAIG
Multi Country Safety Head
Sanofi

SHRADDHA BHANGE
Senior Medical Safety Lead
Sandoz
12:20 - Topic TBC
For sponsorship opportunities please contact info@virtueinsight.com
12:50 – Networking luncheon
13:50 – Panel Discussion - The “Next Generation” risk management strategies
RISK MANAGEMENT
- Implementation and maintenance of RMP’s – Overcoming its challenges
- Potential analyzing of safety and risk signals in PV
- Strategies to minimize the risk measures – what are the new developments?
- Benefit/Risk ratio: the common Denominator
- Stakeholders in RMP – Communications must be improved
- Implementing a Risk-Based Monitoring Solution: Understanding the basics of a sustainable model
- Discussing about the strategies that support the PV from beginning to end
Moderator

VISHWAS SOVANI
Founder Director
Pharmawisdom
Panellists

PRASAD DESHMUKH
Vice President & Head Pharmacovigilance
Cipla

JEROZE DALAL
Head of Clinical Operations, Governance & Risk Management
GSK

CHITRA BARGAJE
Sr.GM, Global Head PV, Drug Safety & Risk Management
Lupin

VASU MORLA
Global GCP/PV Auditor
Novartis

SUNIL HONKALAS
Senior DGM, Medical & PV
Fresenius Kabi
14:40 - Regulations on Pharmacovigilance in India
REGULATORY
- Regulations overview
- Practical scenario/ scope of improvement
- Interface of PV with regulatory
- Best practices across the global on PV practices
Speaker

MARTINA GOMES
Head, Reg Affairs – CH, South Asia
Bayer
15:10 – Afternoon Tea/Coffee
15:40 – External Service/Supplier Qualification: Challenges and Outcomes
Speaker

SHREYA DESHPANDE
Global Development Quality Manager
Novartis
16:10 – Panel Discussion: Outsourcing in Pharmacovigilance: Evolving Models, Strategic Partnerships & Global Impact
OUTSOURCING
- Explore outsourcing as a strategic tool to access expertise and scale operations.
- Evaluate the pros and cons of outsourcing pharmacovigilance activities.
- Understand key concerns around training, infrastructure, and partner readiness.
- Examine cost-efficiency and budget optimization through outsourced PV systems.
- Identify best practices for building strong, effective PV partnerships.
- Learn from successful collaborations that have enhanced global drug safety.
- Respond to rising case volumes with scalable, tech-enabled PV outsourcing models.
- Fostering quality culture in vendor environments
Moderator

ARUNIMA SEN
Associate VP, Product Safety and Risk Management
Viatris
Panellists

MUKESH GORI
Associate Director -ESP Management CMO & PS
Novartis

RAHUL SOMANI
Head- Global Pharmacovigilance
Alkem Laboratories

ROHINI PANDEY
Regional PV Head- SEA
Abbott

VYNIE ANN RAO
Senior Manager
Glenmark

JYOTI KASHID
Manager, Global Patient Safety Operations
Lundbeck (Singapore)
17:00 - Closing remarks and end of conference
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:00 – Chairperson opening remarks
Speaker

PAV RISHIRAJ
Director, Head of Pharmacovigilance
Ipsen
09:10 – Topic TBC
PV FOR FUTURE
Speaker

SABINE POLTERMANN
Head of Country Patient Safety Switzerland
Bristol-Myers Squibb
09:40 – Panel Discussion: Harnessing RWD & RWE: Transforming the Future of Pharmacovigilance
RWD / RWE
Moderator

RUDI SCHEERLINCK
Safety Strategy Lead – Oncology
Healthcare Business of Merck
Panellists

WOLF HENNING GEBHARDT
R&D Scientist Advanced Analytics
Abbott
10:20 - Solution Provider Presentation
For sponsorship opportunities please contact info.uk@virtueinsight.com
10:40 – Morning Coffee/Tea & Discussion
11:10 – Keynote Panel Discussion: Benefit-Risk Excellence: Innovative Approaches to Risk Management
RISK MANAGEMENT & PLANNING
Moderator

MIRCEA CIUCA
Global Head Medical Safety
Organon
Panellists

FELIX ARELLANO
Senior VP and Global Head of Safety & Risk Management
Roche

CHETAN SHATAPATHY
Executive Director & Head, ADC Group, Patient Safety Oncology
AstraZeneca

GAURI UTTURKAR
Benefit Risk Lead (Associate Director)
UCB

LEA GALOVIC
Associate Director¸ Risk Management, Global Patient Safety & PV
Teva

JOHN SOLOMON
Former Head of Pharmacovigilance – UK & Ireland
Sanofi

ARUN RAVINDRAN
Benefit Risk Lead (Late phase Clinical Development Safety)
UCB
12:00 – Solution Provider Presentation
For sponsorship opportunities please contact info.uk@virtueinsight.com
12:30 – Networking luncheon
13:30 – Panel Discussion - Plan, Develop & Implement the PV Audit strategy plan. PV Inspection readiness: What to expect? How ready can we be?
AUDITS & INSPECTIONS
Moderator

MIJAL CHAVDA
Senior Director, Global Head of GxP Inspections & GVP Quality
Kyowa Kirin
Panellists

KARSTEN LOLLIKE
Scientific VP, Deputy QPPV, Global Patient Safety
Novo Nordisk

TEA BABIC
Director, PV Audits & Inspections
Teva

CHRISTIAN MUHL
Senior Director Compliance
GSK

GALINA CORDERO
Head of Pharmacovigilance Dept, QPPV
JSC Farmak
14:20 - Harmonizing Local PV Activity to Improve Efficiency” with the accent on non_EU Countries (Balkan)
REGULATORY
Speaker

MARJAN DZEPAROSKI
Head of Regulatory Affairs, Drug Safety & Intelectual Property
Bionika Pharmaceuticals
14:40 – Panel Discussion: Regulatory Synergy in PV: Challenges, Opportunities & the Road Ahead
OUTSOURCING
Moderator

PAV RISHIRAJ
Director, Head of Pharmacovigilance
Ipsen
Panellists

STEPHANIE MILLICAN
Deputy Director BRE II
MHRA

MICHAEL BEAN
Senior Director, Regulatory Compliance
Johnson & Johnson

CALVIN JOHNSON
Executive Director & Head of International Patient Safety
Bristol-Myers Squibb

TERESA SARAGOCA
Director, Regulatory Affairs & Technical Manager
ITALFARMACO
15:30 - Chairperson’s closing remarks
15:40 – Evening Tea/Coffee and end of the conference
08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.
09:20 – Welcome address and Opening Remarks
09:30 – Keynote Address – Strategy for global PV system inspection readiness
INSPECTION READINESS
- Who needs to be ready
- Factors for consideration when supporting global inspections
- Common areas of non-compliance
- Management of responses
Speaker

RAJ K BHOGAL
Sr. Director, R&D Business Strategy & Operations
Jazz Pharmaceuticals (UK)
10:10 – Keynote Panel Discussion: Pharmacovigilance for Tomorrow: Navigating Challenges and Uncovering Opportunities
CHALLENGES & OPPORTUNITIES
- Tackle data overload and integration barriers in effective PV implementation.
- Examine the gaps between pre-marketing potential and post-marketing reality.
- Question if accelerated drug approvals compromise patient safety.
- Explore complexities in adopting AI and automation within PV systems.
- Discuss challenges in global literature monitoring for drug safety.
- Identify misconceptions, misuse, and underrecognized factors in ADR causation.
Moderator

VIPIN SETHI
VP International Business, Head Global PV Function
Cadila
Panellists

RISHI JAIN
Country Medical Head
Novartis

INDU NAMBIAR
Pharmacovigilance Lead & Country Safety Head
Sanofi

SAKSHI SHRIVASTAVA DESAI
Director, LMS regional Lead APAC
Johnson & Johnson

KRUNAL DALAL
Head Medical Affairs
GSK

GIRISH SANE
GM & Head Pharmacovigilance
Bristol Laboratories

CHAITANYA KULKARNI
GM Pharmacovigilance
Marksans Pharma
11:00 – Morning Coffee/Tea & Discussion
11:30 – Panel Discussion: Patient-Centric Pharmacovigilance: Amplifying the Patient Voice in Drug Safety
PATIENT SAFETY
- Address unconscious bias in pharmacovigilance and explore mitigation strategies.
- Trace the shift from reactive to proactive patient safety models.
- Examine the role of patient input in signal detection and ADR prevention.
- Highlight the importance of protecting vulnerable patient groups.
- Discuss challenges in patient engagement, including tech access and language barriers.
- Emphasize the value of patient-reported outcomes in improving safety reporting and empowerment.
- Explore how public awareness enhances pharmacovigilance systems and data quality.
Moderator

VISHWAS SOVANI
Founder Director
Pharmawisdom
Panellists

VAIBHAV SALVI
Director & Head – Clinical Study Unit, India & South East Asia
Sanofi

SOURABH FULMALI
Global Medical Director – Respiratory
GSK

RENUKA NEOGI
Head & Deputy GM – Global Clinical Quality Management
Sun Pharma

JAMAL BAIG
Multi Country Safety Head
Sanofi

SHRADDHA BHANGE
Senior Medical Safety Lead
Sandoz
12:20 - Topic TBC
For sponsorship opportunities please contact info@virtueinsight.com
12:50 – Networking luncheon
13:50 – Panel Discussion - The “Next Generation” risk management strategies
RISK MANAGEMENT
- Implementation and maintenance of RMP’s – Overcoming its challenges
- Potential analyzing of safety and risk signals in PV
- Strategies to minimize the risk measures – what are the new developments?
- Benefit/Risk ratio: the common Denominator
- Stakeholders in RMP – Communications must be improved
- Implementing a Risk-Based Monitoring Solution: Understanding the basics of a sustainable model
- Discussing about the strategies that support the PV from beginning to end
Moderator

VISHWAS SOVANI
Founder Director
Pharmawisdom
Panellists

PRASAD DESHMUKH
Vice President & Head Pharmacovigilance
Cipla

JEROZE DALAL
Head of Clinical Operations, Governance & Risk Management
GSK

CHITRA BARGAJE
Sr.GM, Global Head PV, Drug Safety & Risk Management
Lupin

VASU MORLA
Global GCP/PV Auditor
Novartis

SUNIL HONKALAS
Senior DGM, Medical & PV
Fresenius Kabi
14:40 - Regulations on Pharmacovigilance in India
REGULATORY
- Regulations overview
- Practical scenario/ scope of improvement
- Interface of PV with regulatory
- Best practices across the global on PV practices
Speaker

MARTINA GOMES
Head, Reg Affairs – CH, South Asia
Bayer
15:10 – Afternoon Tea/Coffee
15:40 – External Service/Supplier Qualification: Challenges and Outcomes
Speaker

SHREYA DESHPANDE
Global Development Quality Manager
Novartis
16:10 – Panel Discussion: Outsourcing in Pharmacovigilance: Evolving Models, Strategic Partnerships & Global Impact
OUTSOURCING
- Explore outsourcing as a strategic tool to access expertise and scale operations.
- Evaluate the pros and cons of outsourcing pharmacovigilance activities.
- Understand key concerns around training, infrastructure, and partner readiness.
- Examine cost-efficiency and budget optimization through outsourced PV systems.
- Identify best practices for building strong, effective PV partnerships.
- Learn from successful collaborations that have enhanced global drug safety.
- Respond to rising case volumes with scalable, tech-enabled PV outsourcing models.
- Fostering quality culture in vendor environments
Moderator

ARUNIMA SEN
Associate VP, Product Safety and Risk Management
Viatris
Panellists

MUKESH GORI
Associate Director -ESP Management CMO & PS
Novartis

RAHUL SOMANI
Head- Global Pharmacovigilance
Alkem Laboratories

ROHINI PANDEY
Regional PV Head- SEA
Abbott

VYNIE ANN RAO
Senior Manager
Glenmark

JYOTI KASHID
Manager, Global Patient Safety Operations
Lundbeck (Singapore)
17:00 - Closing remarks and end of conference
Download Brochure
Event Sponsors
We wouldn’t be able to host our conferences without help from these amazing companies. A huge thanks to all our sponsors and partners!
Gold Sponsors

Conceptualized by

- Phone:+91 44 42108101
- Email:info@virtueinsight.com
Supported by

- Phone:+91 8925031783
- Email:info@conferencenext.com

- Phone:+91 8925031783
- Email:info@conferencealerts.co.in

- Phone:+91-8925031783
- Email:info@internationalconferencealerts.com



- Phone:+91 89250 31783
- Email:info@allconferencealert.com
Event Testimonials
A huge thanks to all our sponsors, attendees and partners!
“I found it to be very well structured, focused on topics of interest for every PV professional. All the speakers were amazing and I look forward attending your future conferences”
The Legal regulatory session on Day was very good. Informative
Very well organised & very interesting topics selected. Time management & allowing to ask questions were very sufficient as well.
Great opportunity for networking and to learn different industry perspectives on PV systems, challenges & regulations.
Insightful sessions, well structured presentations and speakers sharing highly valuable knowledge and experience. Learned a lot even through the networking breaks.
Excellent Meeting. Thanks for the great efforts
The conference was very well organised and speakers were clear and concise. I enjoyed the panel discussions as it was good to hear different opinions which are based on experiences etc.
Well organised, good and interesting topics and speaker.
Very nice opportunity to share own challenges with other Pharmacovigilance experts and hear about future initiatives. I would like to thank Virtue Insight for organising the conference
Good networking opportunity. Balanced topics, good mix of well known speakers and new ones. Interesting Panels.
Good opportunity to network with colleagues. Mostly the speakers/panel members were of high calibre and experienced.
The programme is very diverse and representations from various companies covering many areas of PV System. Very well organised and great opportunity to network with industry colleagues.
The programme is very diverse and representations from various companies covering many areas of PV System. Very well organised and great opportunity to network with industry colleagues.
Kudos to the organizing team – you did it again! A very good networking opportunity, highly recommending this to young professionals as well. Excellent panel discussions and presentations, with a variety of topic of interest, all very actual in the field of pharmacovigilance and beyond. Also not to neglect: great venue and food.
Great Chairperson who shared the Why & vision for PV. Ensured timely sessions with Q&A with interactions. Relevant topics, most speakers were great communicators & panel discussions very useful insights.
Pricing Details
SUPER EARLY BIRD PRICE (Until 11 December 2025)
Individual booking per DELEGATE @ £ 799 + VAT
Group Discount @ £ 1598 + VAT (3 Delegates for the price of 2)
STANDARD PRICE
Individual booking per DELEGATE @ £ 1299 + VAT
Group Discount @ £ 2598 + VAT (3 Delegates for the price of 2)
You can simply email or call and book your conference delegate seats on:
TEL: +44 20 3509 3779 (or) Email — piyush@virtueinsightevents.com
CONFERENCE SPONSOR & EXHIBITION STALL
Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to:
TEL: +44 20 3509 3779 (or) Email — piyush@virtueinsightevents.com
Download Brochure
Venue details
The venue is easily accessible, well-equipped with modern amenities, and offers a comfortable, professional setting for all attendees.
Venue
Sheraton Skyline, Heathrow,
London, UK
Heathrow Airport, Sheraton Heathrow, A4 Bath Rd,
Harlington, Hayes UB3 5BP, United Kingdom
+44 20 8759 2535
Venue – Sheraton Skyline, Heathrow, London, UK
Heathrow Airport, Sheraton Heathrow, A4 Bath Rd, Harlington, Hayes UB3 5BP, United Kingdom
+44 20 8759 2535